EUVIRNA: European Training Network on (+)RNA Virus Replication and Antiviral Drug Development

The successor of EUVIRNA is called ANTIVIRALS! This EU-funded project has started on 1-3-2015 and is now recruiting 15 Early Stage Researchers. Please visit!

EUVIRNA researchers very enthousiastic about the network!

Five Prize Winners at ICAR Symposium!
EUVIRNA fellows have been hugely successful at the ICAR symposium. In their category, EUVIRNA fellows won 5 of the 6 poster prizes.

What is EUVIRNA?
EUVIRNA is a Marie Curie Initial Training Network that is funded under the Framework 7 PEOPLE programme of the European Commission.

EUVIRNA started in 2011 and will end in 2015. By then, 20 excellent young scientists will have been trained in viral replication research and antiviral drug development in an intersectoral training environment. Information on the background and objectives can be found in Background .

EUVIRNA's Activities
EUVIRNA has employed many activities to achieve this training. Most recent and upcoming events are:

  • EUVIRNA's final symposium
    EUVIRNA's final symposium has taken place in consort with the 27th International Conference on Antiviral Research in Raleigh, North Carolina, USA. The EUVIRNA fellows have made a great impression by winning 5 out of 6 poster prizes!
  • EUVIRNA Blog
    Engagement of a broader public is very important. EUVIRNA's fellows have created a EUVIRNA BLOG about interesting subjects in virology. The blog was discussed with Vincent Racaniello, who gave excellent feedback to the posts.
  • Research training workshops
    6 intensive courses on particular scientific subjects and techniques. These courses are summarised in Training courses.
  • Complementary Skills workshops
    8 workshops on skills that are very important to scientists working on the interface of Academia and Industry. Workshops are listed in Training courses
  • (Intersectoral) Secondments in which E(S)Rs learn new techniques and approaches while they are hosted by another partner

Consortium Partners

Academic Partners Industrial PartnersAssociated Partner
Utrecht UniversityJanssen Infectious Diseases Diagnostics BVBAVirology Education
Leiden University Medical CenterRiboxx GmbH
Université d’Aix-MarseilleAratana Therapeutics
University Hospital of Heidelberg 
K.U. Leuven 
Cardiff University